|
|||
| |
|||
Company USA
A nanobiotechnology company developing a next-generation DNA sequencing platform that the company believes will allow an entire human genome to be sequenced for less than $1,000, ultimately enabling personalized medicine.
The company’s platform, Hybridization-Assisted Nanopore Sequencing (HANS) uses nanotechnology-based detectors known as nanopores |
||
| CLICK HERE If you would like to receive contact details for this technology provider or ask a question (s) |
 |
|
Privacy Statement | Terms of Use
T: +44 (0) 1786 474768 E: info@nanoposts.com |
|||||